Recivit sublingual tablets recall
The Medicines and Healthcare products Regulatory Agency has issued a company-led recall for specific batches of Recivit (fentanyl citrate; Grünenthal) sublingual tablets. This is because there is a possibility that certain batches will have blisters that have tablets missing or contain two tablets in a single blister cavity.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067201
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com